PRE 14A

PRE 14A Filing

Company: Processa Pharmaceuticals, Inc.
Filed: September 25, 2023
Period of Report: September 25, 2023
Accession Number: 0001493152-23-033588

View Document ↗ View on SEC.gov ↗